Why Abzena?
Our focused approach.
Abzena welcomes the opportunity to schedule some time to connect on your project-specific needs and to provide you with an update on our expanded global capabilities. From antibodies (mAbs) to recombinant vaccines and bioconjugates- including Antibody-Drug Conjugates (ADCs), Radioconjugates, and Antibody-Oligonucleotide Conjugates (AOCs), our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.
We can provide you with an update on our expanded global capabilities and enhanced platform technology like AbZelectPRO™, our enhanced cell line development solution. AbZelectPRO™ can take you from DNA to RCB in 10 weeks with 8g/L in high-performing titers. If you are ready to achieve more from your cell line and reach IND faster, discover AbZelectPRO™.
Don’t miss our talk on Day 2 of the conference (Tuesday, June 17) our CSO, Campbell Bunce will presenting “Accelerating the Development of Next-Gen Bioconjugates & Bispecifics: From Lead Candidate Design to Manufacture” in the BioProcess Theater (Booth #3335) from 2:40PM – 3:00PM.
Schedule a partnering meeting with our attending drug development experts:
We are also co-hosting a lunch seminar with our partner Argonaut Manufacturing on Wednesday, June 18th at Morton’s Steakhouse, “Removing the White Space: Streamlined Drug Substance & Drug Product Support for Biologics.” For more information or to register, visit: Abzena & Argonaut Manufacturing Lunch Seminar at BIO: Removing the White Space | Abzena